Health4 months ago
Sarepta Shares Surge After HHS Expands Newborn Screening List
Sarepta Therapeutics (SRPT) experienced a notable rise of approximately 6% on Tuesday, October 3, 2023, following an announcement from the U.S. Department of Health and Human...
